Radioisotope Pipeline

A Promising Future Focused on Diagnosis and Treatment

The RadioGenixTM System (technetium Tc 99m generator) is a proprietary, patented platform technology with potential pipeline applications including alpha therapies such as actinium-225 / bismuth-213, and beta therapies and diagnostic imaging agents such as tungsten-188 / rhenium-188, germanium-68 / gallium-68, among others.

Development Stages

Development Scale Engineering & Chemistry
Proof of Concept
Scale-Up
Data Development
NDA
Marketed
molybdenum-99
Parent isotope of Tc-99m, the most widely used medical isotope used to diagnose and stage heart disease, cancer, infection, inflammation and other conditions.
-
actinium-225/bismuth-213
Treatment of cancers such as AML, infectious diseases such as HIV, and potentially certain heart diseases such as atherosclerosis
-
rhenium-188
Treatment of Melanoma
-
gallium-68
Imaging of Neuroendocrine Tumors (NETs)
-
NMT005
-
NMT006
-
NMT007
-

Questions?

Do you have questions about NorthStar, our products, supply solutions, careers or anything else?

Contact Us Today